{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/osteoarthritis/prescribing-information/topical-capsaicin/","result":{"pageContext":{"chapter":{"id":"7859a51d-1efc-5b71-8547-74135120e0c1","slug":"topical-capsaicin","fullItemName":"Topical capsaicin","depth":2,"htmlHeader":"<!-- begin field 51f6b95e-fdd7-4e90-8301-a77500cdd508 --><h2>Topical capsaicin</h2><!-- end field 51f6b95e-fdd7-4e90-8301-a77500cdd508 -->","summary":"","htmlStringContent":"<!-- begin item 5b68e09f-3955-4fab-b866-a77500cdd353 --><!-- end item 5b68e09f-3955-4fab-b866-a77500cdd353 -->","topic":{"id":"de61cfe3-a7fc-50bd-87eb-af7e90b20bfc","topicId":"c9866707-687c-4314-bff3-ae71e0d7e669","topicName":"Osteoarthritis","slug":"osteoarthritis","lastRevised":"Last revised in June 2018","chapters":[{"id":"9674ea7a-b052-5c2f-a0a1-336c67e0622a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aec2334e-8ee7-5d04-902e-c9a904550f17","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"6a895bdb-e3ce-53e5-a302-6bbca48a6e9f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5ae3cd70-eacb-5c4c-98f5-dace0da22472","slug":"changes","fullItemName":"Changes"},{"id":"2723ad88-c2c8-5b92-ac37-5d5af66e900a","slug":"update","fullItemName":"Update"}]},{"id":"3ffc0128-f379-5b16-bfbb-fe9c04753b07","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"740484d6-e553-5d2a-bcbf-22e4b61e30c8","slug":"goals","fullItemName":"Goals"},{"id":"2ab52642-cd7c-5b7d-a3c9-911580e1911c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3bb32b14-2fda-58fa-b09c-cd98270c7adb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"35eeb6be-f0dd-5cde-a148-b87e5da25be5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3a253c38-1fe5-581e-8eff-eb2e5225d071","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"06733eae-d1c5-59d1-a725-266721a216af","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3825aa8e-f0d5-5c9c-89b4-1898289f4fc9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"182bd361-b277-56da-ba91-aec64a5dbc1e","slug":"definition","fullItemName":"Definition"},{"id":"8696aed8-8dba-5a61-a12d-83015e11e6f3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"80accb52-81a2-5799-93cd-5e7582f72276","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"c1ea97e2-1426-5b7d-bde9-716cb3c7eafa","slug":"complications","fullItemName":"Complications"},{"id":"274efaa2-3e84-556a-b637-e3465e12e5e3","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"27d93353-f59d-560a-a997-442790b4886e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"fb6bb640-6ea0-5e5d-ab1e-226ba7b3f1a5","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"3946b5ad-ac52-5fa8-aac6-2336526f17d7","slug":"assessment","fullItemName":"Assessment"},{"id":"258c85c0-fccc-5104-bd56-7b9ad61740f0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"431a0217-fdab-502e-926c-a37e20150d61","fullItemName":"Management","slug":"management","subChapters":[{"id":"281a0a54-9420-5c71-ab29-0e6ac788fdb5","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"157c78c6-0823-59f1-be8e-37716aebc131","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"3c945e6b-1050-57b1-8fb2-52d4675e3b20","slug":"topical-nsaids","fullItemName":"Topical NSAIDs"},{"id":"7859a51d-1efc-5b71-8547-74135120e0c1","slug":"topical-capsaicin","fullItemName":"Topical capsaicin"}]},{"id":"605232dc-8685-5f88-b393-460b958a4e26","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"376de13c-5458-5bd0-987d-d1998635c19a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"098b9a8a-7356-5cc6-8d8e-103f9f4b5c19","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"114aa4f2-a690-5db8-913f-ed5733b88ec7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c4a226d2-7bc7-5f71-822a-bb2115a1e0da","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f5a772c1-6d28-5056-becd-1d1b06be8907","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"c56a97ce-4c02-5076-a99e-b3272c1e9bd4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7ad7c476-7017-5c96-bd7d-25890a8b6390","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"157c78c6-0823-59f1-be8e-37716aebc131","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"9b067eee-221d-59c4-8d3d-4b56dbef76fe","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 9c5d5d79-9b8c-4347-a816-a8ff0150f55b --><h3>Contraindications and cautions</h3><!-- end field 9c5d5d79-9b8c-4347-a816-a8ff0150f55b -->","summary":"","htmlStringContent":"<!-- begin item a3c32179-a554-4d09-80eb-a8ff0150f455 --><!-- begin field d184a208-b717-420b-8262-a8ff0150f55b --><p><strong>Prescribe topical capsaicin with caution:</strong></p><ul><li>Apply sparingly to the skin four times a day, not more often than every four hours.</li><li>Avoid use on broken or inflamed skin, and the eyes — wash hands immediately after application (or 30 minutes after application if hands are treated).</li><li>Avoid taking a hot shower or bath just before or after application — burning sensation may be enhanced.</li><li>Avoid inhalation of vapours.</li><li>Do not use under tight bandages.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/osteoarthritis/references/\">BNF 75, 2018</a>]</p><!-- end field d184a208-b717-420b-8262-a8ff0150f55b --><!-- end item a3c32179-a554-4d09-80eb-a8ff0150f455 -->","subChapters":[]},{"id":"16819137-b2a1-53fd-a5ba-c8b17a538338","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 7843e3a9-a871-4293-aca9-a8ff01510c29 --><h3>Adverse effects</h3><!-- end field 7843e3a9-a871-4293-aca9-a8ff01510c29 -->","summary":"","htmlStringContent":"<!-- begin item b30f4988-5d2b-4208-bb22-a8ff01510b5a --><!-- begin field ba94b78e-3f06-41e1-8514-a8ff01510c29 --><p><strong>Adverse effects of topical capsaicin include:</strong></p><ul><li>Transient burning sensation during initial treatment — particularly if too much preparation is used or if administered less than 3–4 times daily.</li><li>Cough, eye irritation, sneezing (rare).</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/osteoarthritis/references/\">BNF 75, 2018</a>] </p><!-- end field ba94b78e-3f06-41e1-8514-a8ff01510c29 --><!-- end item b30f4988-5d2b-4208-bb22-a8ff01510b5a -->","subChapters":[]},{"id":"52e37ffa-6ec3-5744-b9a0-376198b6ab3d","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field ded68a02-3a51-4e5a-a9ac-a8ff015120b3 --><h3>Drug interactions</h3><!-- end field ded68a02-3a51-4e5a-a9ac-a8ff015120b3 -->","summary":"","htmlStringContent":"<!-- begin item 1217e9b9-5595-4006-a000-a8ff01511fb6 --><!-- begin field 2b33610e-3362-456c-b6de-a8ff015120b3 --><ul><li>There are no documented drug interactions with topical capsaicin use.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/osteoarthritis/references/\">BNF 75, 2018</a>] </p><!-- end field 2b33610e-3362-456c-b6de-a8ff015120b3 --><!-- end item 1217e9b9-5595-4006-a000-a8ff01511fb6 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}